Skip to main content
Erschienen in: Discover Oncology 6/2011

01.12.2011

Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases

verfasst von: Jeffrey G. McDonald, Susan Matthew, Richard J. Auchus

Erschienen in: Discover Oncology | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

The ability to measure steroid hormone concentrations in blood and urine specimens is central to the diagnosis and proper treatment of adrenal diseases. The traditional approach has been to assay each steroid hormone, precursor, or metabolite using individual aliquots of serum, each with a separate immunoassay. For complex diseases, such as congenital adrenal hyperplasia and adrenocortical cancer, in which the assay of several steroids is essential for management, this approach is time consuming and costly, in addition to using large amounts of serum. Gas chromatography/mass spectrometry profiling of steroid metabolites in urine has been employed for many years but only in a small number of specialized laboratories and suffers from slow throughput. The advent of commercial high-performance liquid chromatography instruments coupled to tandem mass spectrometers offers the potential for medium- to high-throughput profiling of serum steroids using small quantities of sample. Here, we review the physical principles of mass spectrometry, the instrumentation used for these techniques, the terminology used in this field and applications to steroid analysis.
Literatur
1.
Zurück zum Zitat Abraham GE (1969) Solid-phase radioimmunoassay of estradiol-17β. J Clin Endocrinol Metab 29:866–870PubMedCrossRef Abraham GE (1969) Solid-phase radioimmunoassay of estradiol-17β. J Clin Endocrinol Metab 29:866–870PubMedCrossRef
2.
Zurück zum Zitat Shackleton CHL (1985) Mass spectrometry: application to steroid and peptide research. Endocr Rev 6:441–486PubMedCrossRef Shackleton CHL (1985) Mass spectrometry: application to steroid and peptide research. Endocr Rev 6:441–486PubMedCrossRef
3.
Zurück zum Zitat Zhang Y, Tobias HJ, Brenna JT (2009) Steroid isotopic standards for gas chromatography–combustion isotope ratio mass spectrometry (GCC-IRMS). Steroids 74:369–378PubMedCrossRef Zhang Y, Tobias HJ, Brenna JT (2009) Steroid isotopic standards for gas chromatography–combustion isotope ratio mass spectrometry (GCC-IRMS). Steroids 74:369–378PubMedCrossRef
4.
Zurück zum Zitat Penning TM, Lee SH, Jin Y, Gutierrez A, Blair IA (2010) Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J Steroid Biochem Mol Biol 121:546–555PubMedCrossRef Penning TM, Lee SH, Jin Y, Gutierrez A, Blair IA (2010) Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J Steroid Biochem Mol Biol 121:546–555PubMedCrossRef
5.
Zurück zum Zitat Yamashita K, Miyashiro Y, Maekubo H, Okuyama M, Honma S, Takahashi M, Numazawa M (2009) Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 74:920–926PubMedCrossRef Yamashita K, Miyashiro Y, Maekubo H, Okuyama M, Honma S, Takahashi M, Numazawa M (2009) Development of highly sensitive quantification method for testosterone and dihydrotestosterone in human serum and prostate tissue by liquid chromatography-electrospray ionization tandem mass spectrometry. Steroids 74:920–926PubMedCrossRef
6.
Zurück zum Zitat Shackleton CH (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127–140PubMedCrossRef Shackleton CH (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127–140PubMedCrossRef
7.
Zurück zum Zitat Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496–504PubMedCrossRef Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH (2010) Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496–504PubMedCrossRef
8.
Zurück zum Zitat Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583–590PubMedCrossRef Therrell BLJ, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S (1998) Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583–590PubMedCrossRef
9.
Zurück zum Zitat Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, Shackleton CH, Reitz RE, Fisher DA (2002) The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 87:3682–3690PubMedCrossRef Caulfield MP, Lynn T, Gottschalk ME, Jones KL, Taylor NF, Malunowicz EM, Shackleton CH, Reitz RE, Fisher DA (2002) The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J Clin Endocrinol Metab 87:3682–3690PubMedCrossRef
10.
Zurück zum Zitat Wudy SA, Hartmann M, Homoki J (2000) Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography–mass spectrometry. J Endocrinol 165:679–683PubMedCrossRef Wudy SA, Hartmann M, Homoki J (2000) Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using benchtop gas chromatography–mass spectrometry. J Endocrinol 165:679–683PubMedCrossRef
11.
Zurück zum Zitat Homma K, Hasegawa T, Takeshita E, Watanabe K, Anzo M, Toyoura T, Jinno K, Ohashi T, Hamajima T, Takahashi Y, Takahashi T, Matsuo N (2004) Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 89:6087–6091PubMedCrossRef Homma K, Hasegawa T, Takeshita E, Watanabe K, Anzo M, Toyoura T, Jinno K, Ohashi T, Hamajima T, Takahashi Y, Takahashi T, Matsuo N (2004) Elevated urine pregnanetriolone definitively establishes the diagnosis of classical 21-hydroxylase deficiency in term and preterm neonates. J Clin Endocrinol Metab 89:6087–6091PubMedCrossRef
12.
Zurück zum Zitat Tiu SC, Chan AO, Taylor NF, Lee CY, Loung PY, Choi CH, Shek CC (2009) Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med J 15:463–470PubMed Tiu SC, Chan AO, Taylor NF, Lee CY, Loung PY, Choi CH, Shek CC (2009) Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. Hong Kong Med J 15:463–470PubMed
13.
Zurück zum Zitat Khorram-Manesh A, Ahlman H, Jansson S, Wangberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE (1998) Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605–611, discussion 611–612PubMedCrossRef Khorram-Manesh A, Ahlman H, Jansson S, Wangberg B, Nilsson O, Jakobsson CE, Eliasson B, Lindstedt S, Tisell LE (1998) Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 22:605–611, discussion 611–612PubMedCrossRef
14.
Zurück zum Zitat Arlt W, Biehl M, Taylor AE, Hahner S, Libe R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96:3775–3784 Arlt W, Biehl M, Taylor AE, Hahner S, Libe R, Hughes BA, Schneider P, Smith DJ, Stiekema H, Krone N, Porfiri E, Opocher G, Bertherat J, Mantero F, Allolio B, Terzolo M, Nightingale P, Shackleton CH, Bertagna X, Fassnacht M, Stewart PM (2011) Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 96:3775–3784
15.
Zurück zum Zitat Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW (2011) Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 44:77–88PubMedCrossRef Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW (2011) Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 44:77–88PubMedCrossRef
16.
Zurück zum Zitat Rauh M (2010) Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 121:520–527PubMedCrossRef Rauh M (2010) Steroid measurement with LC-MS/MS. Application examples in pediatrics. J Steroid Biochem Mol Biol 121:520–527PubMedCrossRef
17.
Zurück zum Zitat Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J (2007) Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92:2581–2589PubMedCrossRef Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J (2007) Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 92:2581–2589PubMedCrossRef
18.
Zurück zum Zitat Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D (2004) Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3687–3693PubMedCrossRef Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D (2004) Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 89:3687–3693PubMedCrossRef
19.
Zurück zum Zitat Guo T, Taylor RL, Singh RJ, Soldin SJ (2006) Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 372:76–82PubMedCrossRef Guo T, Taylor RL, Singh RJ, Soldin SJ (2006) Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta 372:76–82PubMedCrossRef
20.
Zurück zum Zitat Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405–413PubMedCrossRef Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab 92:405–413PubMedCrossRef
21.
Zurück zum Zitat Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH 3rd, Nwariaku FE (2007) “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH 3rd, Nwariaku FE (2007) “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 142:900–905PubMedCrossRef
Metadaten
Titel
Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases
verfasst von
Jeffrey G. McDonald
Susan Matthew
Richard J. Auchus
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Discover Oncology / Ausgabe 6/2011
Print ISSN: 1868-8497
Elektronische ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-011-0099-x

Weitere Artikel der Ausgabe 6/2011

Discover Oncology 6/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.